Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment.
Resource
Oncology,68(4-6),350-355.
Journal
Oncology
Journal Volume
68
Journal Issue
4-6
Pages
350-355
Date Issued
2005-07
Date
2005-07
Author(s)
Yang, CH
Chen, MC
Cheng, AL
Hsu, CH
Kun-Huei, Yeh
Yu, YC
Whang-Peng, J
Yang, PC.
SDGs